Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HPV16/18 Positive”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Not applicableUnknownNCT03206138
What this trial is testing

Safety and Efficacy of GX-188E Administered Via EP Plus GX-I7 or Imiquimod.

Who this might be right for
Cervical Intraepithelial Neoplasia 3
Seoul St. Mary's Hospital 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07303751
What this trial is testing

Study Assessing Reduced HPV Infectivity and Transmission in HPV-Positive Women Following Vaccination With 9vHPV

Who this might be right for
HPVHigh-risk HPV (Any Strain)Human Papillomavirus (HPV) Infections
Institut d'Investigació Biomèdica de Bellvitge 80
Testing effectiveness (Phase 2)Study completedNCT00263744
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of MEDI-517P in Healthy Adult Female Volunteers Who Are HPV-16 or HPV-18 DNA Positive

Who this might be right for
Healthy
MedImmune LLC 60
Not applicableUnknownNCT02411019
What this trial is testing

Safety and Efficacy of GX-188E DNA Therapeutic Vaccine Administered by Electroporation After Observation

Who this might be right for
Cervical Intraepithelial Neoplasia 3
Genexine, Inc. 67
Testing effectiveness (Phase 2)Active Not RecruitingNCT05280457
What this trial is testing

HPV 16-positive and/or HPV 18-positive Recurrent and/or For Patients With Metastatic Head and Neck Cancer to Evaluate GX-188E DNA Vaccination, GX-I7 and Nivolumab Combination Therapy

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Yonsei University 21
Testing effectiveness (Phase 2)Study completedNCT03444376
What this trial is testing

The Combination of GX-188E Vaccination and Pembrolizumab in Patients With HPV 16 and/or 18+ Advanced Cervical Cancer

Who this might be right for
Cervical Cancer
Genexine, Inc. 65
Testing effectiveness (Phase 2)UnknownNCT04800978
What this trial is testing

Combination of Durvalumab and BVAC-C in Patients With HPV 16 or 18 Positive Cervical Cancer Failure to First-Line Platinum-based Chemotherapy

Who this might be right for
Cervical Cancer
Samsung Medical Center 37
Not applicableNot Yet RecruitingNCT07714577
What this trial is testing

Investigator-Initiated Study of BBM-C101 Injection in Subjects With HPV16/18 Infection

Who this might be right for
HPV16/18 Positive
Tianjin First Central Hospital 200
Testing effectiveness (Phase 2)Study completedNCT03603808
What this trial is testing

VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions

Who this might be right for
Anal Intraepithelial NeoplasiaHigh Grade Squamous Intraepithelial NeoplasiaHIV Positivity+2 more
AIDS Malignancy Consortium 44
Post-approval studies (Phase 4)Looking for participantsNCT05334706
What this trial is testing

Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women After Vaccination With 9vHPV (RIFT-HPV)

Who this might be right for
Cervical Intraepithelial Neoplasia Grade I/ II/ III (CIN I/II/III)Human Papillomavirus (HPV) InfectionsHigh-risk HPV+1 more
Miquel Angel Pavon Ribas 69
Testing effectiveness (Phase 2)Looking for participantsNCT07175662
What this trial is testing

Evaluation of NWRD08 for HPV-16 and/or HPV-18 Related Cervical HSIL

Who this might be right for
High-grade Squamous Intraepithelial Lesion (HSIL)
Newish Biotech (Wuxi) Co., Ltd. 150
Not applicableNot Yet RecruitingNCT07606677
What this trial is testing

Peripheral Blood CyTOF Immune Model for Cervical Lesion Detection in HPV16/18+ Women

Who this might be right for
CIN 2/3Cervical Cancer (Early Detection)
Women's Hospital School Of Medicine Zhejiang University 1,465
Early research (Phase 1)Study completedNCT02379520
What this trial is testing

HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA

Who this might be right for
Human Papillomavirus-Related CarcinomaHuman Papillomavirus Positive Oropharyngeal CarcinomaHuman Papillomavirus Positive Cervical Carcinoma+3 more
Baylor College of Medicine 32